Where do we go from here and WHEN? Just my opinion but apparently the FDA and UEEC are on the same page toward the goal of PMA appvoval or why would they have selected the company for the eSTAR pilot program? "The company is awaiting final reports on sterilization and bio burden testing." according to our CEO Brian Thom which sounds like it could be completed soon for submission? Now if your a buyer my eyes just opened wider?
If your a pharm you might want to put an offer on the table. Hmmmm?
Time to pick up a few more shares IMO!
$5-$10.